Beatriz Pérez Gómez-rekin lankidetzan egindako argitalpenak (10)

2022

  1. Evolution of antibodies against SARS-CoV-2 over seven months: Experience of the nationwide seroprevalence ENE-COVID study in Spain

    Journal of Clinical Virology, Vol. 149

2020

  1. Reply to: Comment to: Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors

    European Journal of Cancer Prevention

2019

  1. Antibody responses to flagellin C and Streptococcus gallolyticus pilus proteins in colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

  2. Epstein Barr virus antibody reactivity and gastric cancer: A population-based case-control study

    Cancer Epidemiology, Vol. 61, pp. 79-88

  3. Helicobacter pylori seroprevalence in Spain: Influence of adult and childhood sociodemographic factors

    European Journal of Cancer Prevention, Vol. 28, Núm. 4, pp. 294-303

2017

  1. Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013

    Helicobacter, Vol. 22, Núm. 5

  2. Helicobacter pylori antibody reactivities and colorectal cancer risk in a case-control study in Spain

    Frontiers in Microbiology, Vol. 8, Núm. MAY

  3. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study

    Cancer Epidemiology, Vol. 50, pp. 76-84

2016

  1. Association of Streptococcus gallolyticus subspecies gallolyticus with colorectal cancer: Serological evidence

    International Journal of Cancer, Vol. 138, Núm. 7, pp. 1670-1679

2015

  1. Population-based multicase-control study in common tumors in Spain (MCC-Spain): Rationale and study design

    Gaceta Sanitaria, Vol. 29, Núm. 4, pp. 308-315